R

Ralexar Therapeutics

10 employees

Ralexar Therapeutics focuses on the development of an innovative portfolio of liver X receptor agonists.

Basic info

Sectors

Clinical Trials
Biotechnology
Therapeutics

Date founded

2022

Funding rounds raised

Total raised

$27M

from 1 investors over 1 rounds

R

Ralexar Therapeutics raised $27M on April 30, 2015

Investors: -

FAQ